IgG2b Isotype Control Monoklonaler Antikörper

IgG2b Isotype Control Monoklonal Antikörper für FC

Wirt / Isotyp

Maus / IgG2b, kappa

Getestete Reaktivität

n/a

Anwendung

FC

Konjugation

APC Fluorescent Dye

Publikationen(4)

CloneNo.

MPC-11

Kat-Nr. : APC-65128

Synonyme

Ighg2b, MPC-11, Igh-3, IgG2b, gamma2b



Geprüfte Anwendungen

Erfolgreiche Detektion in FChumane PBMCs

Empfohlene Verdünnung

AnwendungVerdünnung
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

FCSee 3 publications below

Produktinformation

APC-65128 bindet in FC IgG2b Isotype Control und zeigt Reaktivität mit n/a

Getestete Reaktivität n/a
Wirt / Isotyp Maus / IgG2b, kappa
Klonalität Monoklonal
Typ Antikörper
Immunogen k.A.
Vollständiger Name immunoglobulin heavy chain 3 (serum IgG2b)
Gene symbol IgG2b Isotype Control
Gene ID (NCBI) 16016
Konjugation APC Fluorescent Dye
Excitation/Emission maxima wavelengths650 nm / 660 nm
Form Liquid
Reinigungsmethode Affinitätsreinigung
Lagerungspuffer PBS with 0.09% sodium azide and 0.5% BSA
LagerungsbedingungenStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Hintergrundinformationen

The MPC-11 immunoglobulin is useful as an isotype-matched control. The MPC-11 immunoglobulin has an unknown binding specificity and is used as an isotype control for mouse IgG2b antibodies. This antibody has been quality-tested for flow cytometry as negative control.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
FC protocol for APC IgG2b Isotype Control antibody APC-65128Download protocol
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
FC

MedComm (2020)

CircMALAT1 promotes cancer stem-like properties and chemoresistance via regulating Musashi-2/c-Myc axis in esophageal squamous cell carcinoma

Authors - Zitong Zhao

Adv Mater

An OMV-Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy

Authors - Yichao Lu
FC

Eur J Pharmacol

PPARγ agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation

Authors - Xiao Jia
FC

Auris Nasus Larynx

Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma

Authors - Yuji Hayashi